Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Back to Articles
Research8 min readApril 6, 2026
Tirzepatide Before and After: Real Results
What to realistically expect from tirzepatide treatment. Typical weight loss timelines and factors that affect results.
By Med Consumer Watch Team
Tirzepatide (Mounjaro/Zepbound) has produced impressive weight loss results in clinical trials. Here's what the data shows and what you can realistically expect.
Clinical Trial Results
SURMOUNT-1 trial findings at 72 weeks:
• 5mg dose: Average 15% body weight loss
• 10mg dose: Average 19.5% body weight loss
• 15mg dose: Average 20.9% body weight loss
• About 1 in 3 participants lost >25% of body weight
These are average results—individual outcomes vary significantly.
Typical Timeline
What to expect over time:
- Month 1-2: Initial 3-5% weight loss, appetite changes noticeable
- Month 3-4: Significant loss begins, 8-12% cumulative
- Month 6: Most people see 12-18% total loss
- Month 12: Results plateau near maximum effect
- Month 18+: Maintenance phase
Weight loss is fastest during the titration phase and slows as you reach higher doses.
Factors Affecting Results
What influences your outcome:
• Starting weight - higher starting weight often means more pounds lost
• Diet quality - medication works better with healthy eating
• Physical activity - exercise improves results
• Dose achieved - higher doses typically mean more loss
• Individual metabolism - genetics play a role
• Consistency - staying on medication matters
Setting Realistic Expectations
Important perspective:
• Not everyone loses 20%+ — that's the high end
• 10-15% loss is still excellent for health
• Some people respond less dramatically
• Side effects may limit dose escalation
• Results require ongoing treatment to maintain
Social media often showcases best-case scenarios. Clinical trial averages are more representative than viral transformations.
The Bottom Line
Tirzepatide produces the most weight loss of any currently available medication, with average losses of 15-21% of body weight. However, individual results vary widely. Focus on health improvements rather than comparing yourself to dramatic before-and-after photos. Even modest weight loss provides significant health benefits.
Sources & References
- SURMOUNT-1 Clinical Trial Results
- New England Journal of Medicine - Tirzepatide Studies
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.
Med Consumer Watch GLP-1 plans
GLP-1 weight loss.
A brand on your side.
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Why choose Med Consumer Watch?
Know your full price
Medication, clinician review and shipping are included. See your total before you buy.
Same price at every included dose
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Support beyond your prescription
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Buy semaglutide
Compounded
Tirzepatide
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.